Harrow Inc. (HROW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Harrow Inc. (HROW:NASDAQ), powered by AI.

Current Price
$38.40
P/E Ratio
-274.7
Market Cap
1.4B
Sector
Healthcare
What is the Harrow Inc. stock price forecast?

Harrow Inc. is currently trading at $38.40. View real-time AI analysis on Alpha Lenz.

What is Harrow Inc. insider trading activity?

View the latest insider trading data for Harrow Inc. on Alpha Lenz.

What is Harrow Inc.'s P/E ratio?

Harrow Inc.'s P/E ratio is -274.7.

Harrow Inc.

NASDAQ · HROW
$38.40-0.53(-1.36%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Harrow Inc.'s future dividend policy...
Alpha Chat Insight

Harrow Inc. trades at a P/E of -274.7 (undervalued) with modest ROE of -8.4%. 3Y revenue CAGR of 45.4% highlights clear growth momentum.

Ask for details

Company Overview

Harrow Inc. is a notable player in the healthcare and pharmaceutical sector, primarily focused on the development, production, and distribution of innovative medicines. The company's core competency is in ophthalmology, where it has established a reputation for delivering effective treatments for a range of eye conditions. Harrow Inc. not only pioneers in providing high-quality formulations but also commits to making these treatments affordable and accessible, aiming to address critical gaps in the market. Headquartered in the United States, Harrow Inc. operates a dynamic business model that includes both proprietary products and important generic formulations, catering to a diverse array of healthcare needs. Its significant role in the pharmaceutical industry is underscored by its impact on improving patient outcomes and its dedication to clinical excellence. By focusing on a vital area of healthcare, Harrow Inc. contributes to the overall enhancement of consumer quality of life and supports healthcare providers with essential, reliable products.

CEOMr. Mark L. Baum J.D.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees382

Company Statistics

FY 2025

Profile

$1.41BMarket Cap
$272.30MRevenue
0.00Shares Out
382Employees

Margins

75.05%Gross
18.45%EBITDA
11.21%Operating
-0.50%Pre-Tax
-1.89%Net

Valuation

-274.68P/E
26.92P/B
5.18EV/Sales
31.65EV/EBITDA
33.01P/FCF

Growth (CAGR)

45.39%Rev 3Yr
40.99%Rev 5Yr
151.47%Op Inc 3Yr
109.95%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.30%ROA
-8.42%ROE
5.79%ROIC

Financial Health

$72.93MCash & Cash Equivalents
$274.46MNet Debt
666.89%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Harrow Inc. (ticker: HROW) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 382 employees. Market cap is $1.4B.

The current price is $38.4 with a P/E ratio of -274.68x and P/B of 26.92x.

ROE is -8.42% and operating margin is 11.21%. Annual revenue is $272M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Harrow Inc. (HROW) Stock Forecast 2026 $38.40 — Price, Financials & Analyst Targets | Alpha Lenz